IMI ND4BB & COMBACTE: A collaborative way to develop novel drugs

“IMI ND4BB & COMBACTE: A Collaborative Way to Develop Drugs”

Hasan Jafri of AstraZeneca joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘IMI ND4BB & COMBACTE: A Collaborative Way to Develop Drugs’. 

In this presentation, learn in-depth information about the Innovative Medicines Initiative (IMI), New Drugs for Bad Bugs (ND4BB), and COMBACTE programs and their efforts against AMR.

Download the presentation to understand more about:

  • How bad is antimicrobial resistance?
  • ND4BB vision
  • The 4 pillars of COMBACTE/CARE/MAGNET

…and much more!

Get your copy here!

To find out how IMI, ND4BB, and COMBACTE are fighting AMR, attend World Anti-Microbial Resistance Congress 2016 held September 8-9 in Washington, DC.

Attend World Anti-Microbial Resistance USA 2016

Leave a Reply

Your email address will not be published. Required fields are marked *